Latest Headlines

• 

  Ironwood Pharmaceuticals Earnings: Here’s Why Investors Don’t Like These Results

  Derek Hoffman   | Tue, Apr 23 |  Comment
• 

  NextEra Energy Price Target Raised and 4 More Analyst Notes to Read

  Alex Capel   | Wed, Mar 13 |  Comment
• 

  Cramer: Buy Honeywell and Sell Herbalife, Ironwood Pharma and This Underperformer

  Alex Capel   | Fri, Jan 18 |  Comment
• 

  ARM Holdings Downgraded to Neutral and 4 Downgraded Stocks to Watch

  Alex Capel   | Wed, Jan 16 |  Comment
• 

  Apple Reiterated at Buy and 4 Reiterated Ratings to Recognize

  Alex Capel   | Wed, Jan 16 |  Comment
• 

  Is Forest Laboratories a Buy Now?

  Dan Moskowitz   | Tue, Jan 15 |  Comment
• 

  Ironwood Pharma Reiterated at Sell and 3 Reiterated Ratings Not To Miss

  Alex Capel   | Wed, Dec 19 |  Comment
• 

  Urban Outfitters Poised to Move Higher and 3 Stock Analyses to Note

  Leah Powell   | Tue, Nov 20 |  Comment
• 

  Cubist Pharma Initiated at Neutral and 2 Initiated Shares on the Move

  Alex Capel   | Fri, Nov 9 |  Comment
• 

  Nike Analyst Deems 10%-15% Dividend Increase Plausible and 3 Must-See Stock Analyses

  Deann Marin   | Wed, Oct 24 |  Comment
• 

  Amarin Gets Patents, AstraZeneca Works With Ironwood: Healthcare Business Update

  Mark Lawson   | Tue, Oct 23 |  Comment
• 

  How Healthy are Healthcare Stocks?

  Meghan Foley   | Tue, Oct 23 |  Comment